Simplex Trading’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-5
| Closed | -$343 | – | 8263 |
|
|
2019
Q2 | $0 | Sell |
5
-2,049
| -100% | -$121K | ﹤0.01% | 8251 |
|
|
2019
Q1 | $143K | Sell |
2,054
-1,532
| -43% | -$114K | ﹤0.01% | 3963 |
|
|
2018
Q4 | $230K | Buy |
+3,586
| New | +$251K | ﹤0.01% | 2999 |
|
|
2018
Q3 | – | Sell |
-1,415
| Closed | -$82.8K | – | 8467 |
|
|
2018
Q2 | $71K | Sell |
1,415
-2,824
| -67% | -$112K | ﹤0.01% | 4688 |
|
|
2018
Q1 | $132K | Buy |
4,239
+980
| +30% | +$32.5K | 0.01% | 1581 |
|
|
2017
Q4 | $111K | Buy |
+3,259
| New | +$104K | ﹤0.01% | 1725 |
|
|
2016
Q3 | – | Sell |
-136
| Closed | -$3K | – | 6820 |
|
|
2016
Q2 | $3K | Sell |
136
-126
| -48% | -$3.35K | ﹤0.01% | 4770 |
|
|
2016
Q1 | $6K | Buy |
262
+198
| +309% | +$5.43K | ﹤0.01% | 4000 |
|
|
2015
Q4 | $2K | Sell |
64
-787
| -92% | -$21.1K | ﹤0.01% | 4672 |
|
|
2015
Q3 | $18K | Buy |
851
+286
| +51% | +$7.37K | ﹤0.01% | 2932 |
|
|
2015
Q2 | $15K | Buy |
565
+36
| +7% | +$1.01K | ﹤0.01% | 2736 |
|
|
2015
Q1 | $16K | Buy |
+529
| New | +$16.8K | ﹤0.01% | 2529 |
|
Simplex Trading's GHDX Position: Q3 2019 in Review
Simplex Trading sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 5 shares — an estimated $343 sold.
Simplex Trading first reported a position in GHDX in Q1 2015 and held it in 12 quarters. The position peaked at $230K in Q4 2018. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.
- Simplex Trading reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
- Simplex Trading sold 5 Genomic Health, Inc. shares in Q3 2019, an estimated $343.
- Simplex Trading first reported a position in Genomic Health, Inc. in Q1 2015 and held it in 12 quarters.
- Simplex Trading's Genomic Health, Inc. position peaked at $230K in Q4 2018.
- 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.
Based on Simplex Trading's 13F filing for Q3 2019, filed 15 Oct 2019.